Risk of Malignancy Index 3 (RMI3) Performance as a Predictor Advanced Stage Epithelial Ovarian Carcinoma used for NACT

Most read articles by the same author(s)

• Tatit Nurseta, Yahya Irwanto, Nugrahanti Prasetyorini, Bambang Rahardjo, I Wayan Subage, Risk of Malignancy Index 4 (RMI4) and Risk of Malignancy Index 3 (RMI3) as Diagnostic Tests for Adnexal Tumor , Indonesian Journal of Obstetrics and Gynecology: Volume 8 No. 4 October 2020
• Tatit Nurseta, Yahya Irwanto, Imelda Imelda, Curcumin Administration on Proliferation and Apoptosis Index in Complete Hydatidiform Mole CellCulture , Indonesian Journal of Obstetrics and Gynecology: Volume. 4, No. 1, January 2016
• Tatit Nurseta, Arsana Wijasa, Barlian Sitompul, Impact of Ethinyl Estradiol to Human Telomerase Reverse Transcriptase Activity on Complete Hydatidiform Mole Culture , Indonesian Journal of Obstetrics and Gynecology: Volume. 4, No. 2, April 2016
• Yahya Irwanto, Expression of Fas Ligand is Higher in Early Stage Cervical Cancer with Lymph Nodes Metastasis , Indonesian Journal of Obstetrics and Gynecology: Volume. 36, No. 4, October 2012
• Tatit Nurseta, The effect of 17β Estradiol Exposure on Mutant p53 Expression in Hydatidiform Mole Trophoblast Cell Culture , Indonesian Journal of Obstetrics and Gynecology: Volume. 35, No. 1, January 2011
• Suryanti, Mayasari Putri Ardela, Eka Frenty Hadiningsih, Sri Winarsih, Noorhamdani, Tatit Nurseta, Eviana Norahmawati, Effect of Bengkoang (Pachyrhizus erosus) Extract on Estrogen Receptor-?, Progesterone Receptor Expression, and Follicle-Stimulating Hormone Levels , Indonesian Journal of Obstetrics and Gynecology: Volume 13. No. 3 July 2025